Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Generic Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2018-2029)
2.2 Generic Drugs Growth Trends by Region
2.2.1 Global Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Generic Drugs Historic Market Size by Region (2018-2024)
2.2.3 Generic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Generic Drugs Market Dynamics
2.3.1 Generic Drugs Industry Trends
2.3.2 Generic Drugs Market Drivers
2.3.3 Generic Drugs Market Challenges
2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drugs Players by Revenue
3.1.1 Global Top Generic Drugs Players by Revenue (2018-2024)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drugs Revenue
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2022
3.5 Generic Drugs Key Players Head office and Area Served
3.6 Key Players Generic Drugs Product Solution and Service
3.7 Date of Enter into Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2018-2024)
4.2 Global Generic Drugs Forecasted Market Size by Type (2024-2029)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2018-2024)
5.2 Global Generic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Generic Drugs Market Size (2018-2029)
6.2 North America Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Generic Drugs Market Size by Country (2018-2024)
6.4 North America Generic Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drugs Market Size (2018-2029)
7.2 Europe Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Generic Drugs Market Size by Country (2018-2024)
7.4 Europe Generic Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drugs Market Size (2018-2029)
8.2 Asia-Pacific Generic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Generic Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Generic Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drugs Market Size (2018-2029)
9.2 Latin America Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Generic Drugs Market Size by Country (2018-2024)
9.4 Latin America Generic Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drugs Market Size (2018-2029)
10.2 Middle East & Africa Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Generic Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Generic Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Generic Drugs Introduction
11.1.4 Teva Revenue in Generic Drugs Business (2018-2024)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Generic Drugs Introduction
11.2.4 Novartis Revenue in Generic Drugs Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Viatris
11.3.1 Viatris Company Detail
11.3.2 Viatris Business Overview
11.3.3 Viatris Generic Drugs Introduction
11.3.4 Viatris Revenue in Generic Drugs Business (2018-2024)
11.3.5 Viatris Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2024)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Company Detail
11.5.2 Aspen Pharmacare Business Overview
11.5.3 Aspen Pharmacare Generic Drugs Introduction
11.5.4 Aspen Pharmacare Revenue in Generic Drugs Business (2018-2024)
11.5.5 Aspen Pharmacare Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Drugs Introduction
11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2018-2024)
11.6.5 Fresenius Kabi Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Generic Drugs Introduction
11.7.4 Sanofi Revenue in Generic Drugs Business (2018-2024)
11.7.5 Sanofi Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Detail
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Generic Drugs Introduction
11.8.4 Aurobindo Revenue in Generic Drugs Business (2018-2024)
11.8.5 Aurobindo Recent Development
11.9 Lupin
11.9.1 Lupin Company Detail
11.9.2 Lupin Business Overview
11.9.3 Lupin Generic Drugs Introduction
11.9.4 Lupin Revenue in Generic Drugs Business (2018-2024)
11.9.5 Lupin Recent Development
11.10 Dr. Reddy's
11.10.1 Dr. Reddy's Company Detail
11.10.2 Dr. Reddy's Business Overview
11.10.3 Dr. Reddy's Generic Drugs Introduction
11.10.4 Dr. Reddy's Revenue in Generic Drugs Business (2018-2024)
11.10.5 Dr. Reddy's Recent Development
11.11 Apotex
11.11.1 Apotex Company Detail
11.11.2 Apotex Business Overview
11.11.3 Apotex Generic Drugs Introduction
11.11.4 Apotex Revenue in Generic Drugs Business (2018-2024)
11.11.5 Apotex Recent Development
11.12 Cipla
11.12.1 Cipla Company Detail
11.12.2 Cipla Business Overview
11.12.3 Cipla Generic Drugs Introduction
11.12.4 Cipla Revenue in Generic Drugs Business (2018-2024)
11.12.5 Cipla Recent Development
11.13 ENDO
11.13.1 ENDO Company Detail
11.13.2 ENDO Business Overview
11.13.3 ENDO Generic Drugs Introduction
11.13.4 ENDO Revenue in Generic Drugs Business (2018-2024)
11.13.5 ENDO Recent Development
11.14 Stada Arzneimittel
11.14.1 Stada Arzneimittel Company Detail
11.14.2 Stada Arzneimittel Business Overview
11.14.3 Stada Arzneimittel Generic Drugs Introduction
11.14.4 Stada Arzneimittel Revenue in Generic Drugs Business (2018-2024)
11.14.5 Stada Arzneimittel Recent Development
11.15 Bausch Health
11.15.1 Bausch Health Company Detail
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Generic Drugs Introduction
11.15.4 Bausch Health Revenue in Generic Drugs Business (2018-2024)
11.15.5 Bausch Health Recent Development
11.16 Hikma
11.16.1 Hikma Company Detail
11.16.2 Hikma Business Overview
11.16.3 Hikma Generic Drugs Introduction
11.16.4 Hikma Revenue in Generic Drugs Business (2018-2024)
11.16.5 Hikma Recent Development
11.17 Torrent
11.17.1 Torrent Company Detail
11.17.2 Torrent Business Overview
11.17.3 Torrent Generic Drugs Introduction
11.17.4 Torrent Revenue in Generic Drugs Business (2018-2024)
11.17.5 Torrent Recent Development
11.18 Glenmark
11.18.1 Glenmark Company Detail
11.18.2 Glenmark Business Overview
11.18.3 Glenmark Generic Drugs Introduction
11.18.4 Glenmark Revenue in Generic Drugs Business (2018-2024)
11.18.5 Glenmark Recent Development
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Detail
11.19.2 Piramal Pharma Business Overview
11.19.3 Piramal Pharma Generic Drugs Introduction
11.19.4 Piramal Pharma Revenue in Generic Drugs Business (2018-2024)
11.19.5 Piramal Pharma Recent Development
11.20 Sawai Pharmaceutical
11.20.1 Sawai Pharmaceutical Company Detail
11.20.2 Sawai Pharmaceutical Business Overview
11.20.3 Sawai Pharmaceutical Generic Drugs Introduction
11.20.4 Sawai Pharmaceutical Revenue in Generic Drugs Business (2018-2024)
11.20.5 Sawai Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Generic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Generic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Generic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Generic Drugs Market Share by Region (2018-2024)
Table 9. Global Generic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Generic Drugs Market Share by Region (2024-2029)
Table 11. Generic Drugs Market Trends
Table 12. Generic Drugs Market Drivers
Table 13. Generic Drugs Market Challenges
Table 14. Generic Drugs Market Restraints
Table 15. Global Generic Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Generic Drugs Market Share by Players (2018-2024)
Table 17. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
Table 18. Ranking of Global Top Generic Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Generic Drugs Product Solution and Service
Table 22. Date of Enter into Generic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Generic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Generic Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Generic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Generic Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Generic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Generic Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Generic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Generic Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Generic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Generic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Generic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Generic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Generic Drugs Product
Table 50. Teva Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Generic Drugs Product
Table 55. Novartis Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Viatris Company Detail
Table 58. Viatris Business Overview
Table 59. Viatris Generic Drugs Product
Table 60. Viatris Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 61. Viatris Recent Development
Table 62. Sun Pharmaceutical Company Detail
Table 63. Sun Pharmaceutical Business Overview
Table 64. Sun Pharmaceutical Generic Drugs Product
Table 65. Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 66. Sun Pharmaceutical Recent Development
Table 67. Aspen Pharmacare Company Detail
Table 68. Aspen Pharmacare Business Overview
Table 69. Aspen Pharmacare Generic Drugs Product
Table 70. Aspen Pharmacare Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 71. Aspen Pharmacare Recent Development
Table 72. Fresenius Kabi Company Detail
Table 73. Fresenius Kabi Business Overview
Table 74. Fresenius Kabi Generic Drugs Product
Table 75. Fresenius Kabi Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 76. Fresenius Kabi Recent Development
Table 77. Sanofi Company Detail
Table 78. Sanofi Business Overview
Table 79. Sanofi Generic Drugs Product
Table 80. Sanofi Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Aurobindo Company Detail
Table 83. Aurobindo Business Overview
Table 84. Aurobindo Generic Drugs Product
Table 85. Aurobindo Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 86. Aurobindo Recent Development
Table 87. Lupin Company Detail
Table 88. Lupin Business Overview
Table 89. Lupin Generic Drugs Product
Table 90. Lupin Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 91. Lupin Recent Development
Table 92. Dr. Reddy's Company Detail
Table 93. Dr. Reddy's Business Overview
Table 94. Dr. Reddy's Generic Drugs Product
Table 95. Dr. Reddy's Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 96. Dr. Reddy's Recent Development
Table 97. Apotex Company Detail
Table 98. Apotex Business Overview
Table 99. Apotex Generic Drugs Product
Table 100. Apotex Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 101. Apotex Recent Development
Table 102. Cipla Company Detail
Table 103. Cipla Business Overview
Table 104. Cipla Generic Drugs Product
Table 105. Cipla Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 106. Cipla Recent Development
Table 107. ENDO Company Detail
Table 108. ENDO Business Overview
Table 109. ENDO Generic Drugs Product
Table 110. ENDO Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 111. ENDO Recent Development
Table 112. Stada Arzneimittel Company Detail
Table 113. Stada Arzneimittel Business Overview
Table 114. Stada Arzneimittel Generic Drugs Product
Table 115. Stada Arzneimittel Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 116. Stada Arzneimittel Recent Development
Table 117. Bausch Health Company Detail
Table 118. Bausch Health Business Overview
Table 119. Bausch Health Generic Drugs Product
Table 120. Bausch Health Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 121. Bausch Health Recent Development
Table 122. Hikma Company Detail
Table 123. Hikma Business Overview
Table 124. Hikma Generic Drugs Product
Table 125. Hikma Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 126. Hikma Recent Development
Table 127. Torrent Company Detail
Table 128. Torrent Business Overview
Table 129. Torrent Generic Drugs Product
Table 130. Torrent Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 131. Torrent Recent Development
Table 132. Glenmark Company Detail
Table 133. Glenmark Business Overview
Table 134. Glenmark Generic Drugs Product
Table 135. Glenmark Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 136. Glenmark Recent Development
Table 137. Piramal Pharma Company Detail
Table 138. Piramal Pharma Business Overview
Table 139. Piramal Pharma Generic Drugs Product
Table 140. Piramal Pharma Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 141. Piramal Pharma Recent Development
Table 142. Sawai Pharmaceutical Company Detail
Table 143. Sawai Pharmaceutical Business Overview
Table 144. Sawai Pharmaceutical Generic Drugs Product
Table 145. Sawai Pharmaceutical Revenue in Generic Drugs Business (2018-2024) & (US$ Million)
Table 146. Sawai Pharmaceutical Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drugs Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Generic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Generic Drugs Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Generic Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Generic Drugs Report Years Considered
Figure 12. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Generic Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Generic Drugs Market Share by Players in 2022
Figure 16. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2022
Figure 18. North America Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Generic Drugs Market Share by Country (2018-2029)
Figure 20. United States Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Generic Drugs Market Share by Country (2018-2029)
Figure 24. Germany Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Generic Drugs Market Share by Region (2018-2029)
Figure 32. China Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Generic Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Generic Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Teva Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 47. Novartis Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 48. Viatris Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 50. Aspen Pharmacare Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 51. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 52. Sanofi Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 53. Aurobindo Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 54. Lupin Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 55. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 56. Apotex Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 57. Cipla Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 58. ENDO Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 59. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 60. Bausch Health Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 61. Hikma Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 62. Torrent Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 63. Glenmark Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 64. Piramal Pharma Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 65. Sawai Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed